U.S. markets open in 4 hours 18 minutes
  • S&P Futures

    4,137.50
    +19.50 (+0.47%)
     
  • Dow Futures

    33,747.00
    +123.00 (+0.37%)
     
  • Nasdaq Futures

    13,884.50
    +85.75 (+0.62%)
     
  • Russell 2000 Futures

    2,267.10
    +22.10 (+0.98%)
     
  • Crude Oil

    62.92
    -0.23 (-0.36%)
     
  • Gold

    1,748.50
    +12.20 (+0.70%)
     
  • Silver

    25.68
    +0.16 (+0.63%)
     
  • EUR/USD

    1.1986
    +0.0003 (+0.02%)
     
  • 10-Yr Bond

    1.6380
    0.0000 (0.00%)
     
  • Vix

    16.86
    +0.21 (+1.26%)
     
  • GBP/USD

    1.3785
    +0.0004 (+0.03%)
     
  • USD/JPY

    108.7720
    -0.1550 (-0.14%)
     
  • BTC-USD

    62,710.01
    -1,909.36 (-2.95%)
     
  • CMC Crypto 200

    1,368.63
    -7.15 (-0.52%)
     
  • FTSE 100

    6,971.03
    +31.45 (+0.45%)
     
  • Nikkei 225

    29,642.69
    +21.70 (+0.07%)
     

EU concludes preliminary talks to buy up to 200 mln doses of Novavax COVID vaccine

  • Oops!
    Something went wrong.
    Please try again later.

BRUSSELS, Dec 17 (Reuters) - The European Union has concluded preliminary talks with U.S. firm Novavax to secure up to 200 million doses of its COVID-19 vaccine candidate, a Commission spokesman said on Thursday.

"The envisaged contract foresees the possibility for member states to buy 100 million doses with the option of buying another 100 million doses," the spokesman said. (Reporting by Francesco Guarascio @fraguarascio and Robin Emmott)